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Table 1
Parameter
LMCA
N30
Proximal
epicardial
N30 p-value*
Epicardial
N255 p-value*
Average LA
(mm2)
15.23.9 10.03.8 0.001 8.53.6 0.001
Average
plaque area
(mm2)
7.42.8 6.33.0 0.085 5.32.9 0.001
PAV 32.68.0 38.414.1 0.059 37.013.6 0.09
Average EEM
area (mm2)
22.65.4 16.44.5 0.001 13.84.9 0.001
EI 3.2 (2.9,3.9) 6.7 (3.3,9.1) 0.001 5.2 (3.7,9.1) 0.001
#Change in
LA (mm2)
Within
segment p-
value
0.100.22
(0.65)
0.0100.23
(0.98)
0.72 0.190.07
(0.004)
0.44
% change in
LA Within
segment p-
value
0.101.8
(0.98)
4.202.1
(0.51)
0.59 3.30.77
(0.001)
0.17
PAV  percent atheroma volume; EEM  external elastic membrane; EI  eccentricity index.
*In comparison to the LMCA segment.
#Least squares means from a mixed model adjusting for baseline measurements.
Changes in LA are in response to IC salbutamol administered via the guiding catheter.
Conclusions: Endothelium-dependent vasomotion is heterogenous within the conduit
system. Despite similar degrees of plaque burden, the LMCA and its most adjacent
epicardial segment display greater degrees of vascular stiffness than the remainder of the
more distal epicardial tree. These observations may provide mechanistic insights into the
focal nature of coronary plaque progression and stability in vivo.
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Background: Fractional flow reserve (FFR) guided percutaneous coronary intervention
(PCI) has been validated in the FAME trial, which demonstrated a statistically significant
reduction in the composite of death or myocardial infarction compared to an
angiographic-guided approach. At two years of follow-up, 3.2% of patients who had
deferral of a FFR negative stenosis ( 0.80) returned for revascularization of the deferred
lesion. Only 0.2% of the deferred lesions resulted in a late myocardial infarction (MI). We
sought to evaluate the outcomes of FFR-deferred lesions in a community-based cardiac
referral center.
Methods: A retrospective analysis was conducted of the FFR cases performed at Kaiser
Permanente Medical Center in Santa Clara, CA over a two-year period. Outcomes of the
patients who had deferral of FFR negative lesions were assessed out to two years.
Results: 5,558 patients underwent diagnostic coronary catheterization from 2010-2011.
FFR was performed on 219 patients with a total of 224 intermediate coronary lesions
undergoing hemodynamic FFR assessment. 144 stenoses (64.3% of total FFRs) were
found to be 0.80 and PCI was deferred in these 140 patients. From this cohort, 38
lesions from a total of 32 patients returned for subsequent coronary angiography. Reasons
for repeat angiography included post-cardiac transplant surveillance, stable angina,
unstable angina, or MI. Of the 32 patients, 10 patients (7.1% of total deferred FFR
patients) underwent revascularization of the originally deferred lesion, with 8 undergoing
PCI and 2 undergoing CABG surgery. Average length from deferral to subsequent
revascularization was 257 days. None of the originally deferred lesions resulted in a late
MI or in-hospital death out to two years of follow-up.
Conclusions: Fractional flow reserve assessment has been increasingly adopted at our
cardiac referral center and accounted for 3.9% of patients that underwent coronary
angiography over the initial two years of adoption. FFR-guided therapy yielded outcomes
that were comparable to that seen in the FAME study, with 7.1% of deferred lesions
requiring revascularization and no deferred stenosis resulting in a subsequent MI or
in-hospital death.
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Background: It is not well known whether endothelial dysfunction after drug-eluting
stent (DES) implantation affects the prognosis. Purpose: We tried to find the predictors of
cardiovascular events after successful DES implantation.
Methods: A consecutive 122 patients who underwent successful first generation DES
(Cypher, Cordis Corp., Miami Lakes, Florida and Taxus, Boston Scientific, Natick,
Massachusetts) implantation and had no residual stenosis at follow-up coronary angiog-
raphy (CAG) were included. All patients also underwent acetylcholine provocation test
(ACh) at follow-up CAG. Definition of positive ACh test (ACh	) was 90% stenosis
with symptom and ischemic electrocardiographic change. Age, sex, coronary risk factors
(smoking, hypertension, diabetes mellitus, dyslipidemia), medication (calcium channel
blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors, ni-
trates, blockers, statins), duration from stent implantation to follow-up CAG (15.514.5
months), old myocardial infarction, ACh	 were included as variables for multivariate
analysis for cardiovascular events (angina pectoris without intervention, acute myocardial
infarction, definite or probable stent thrombosis, cardiac death, and stroke.
Results: ACh provocation test was positive in 64.8%. The following events occurred
during mean follow-up period of 26.99.5 months; angina pectoris without intervention
in 12, very late stent thrombosis in 1 , acute myocardial infarction in 1, sudden death in
1, and stroke in 4. Table shows the results of multinomial Cox and logistic regression
models. Since data of ACh did not fit the conditions of a proportional Hazard model, it
used multinomial logistic regression.
Independent Predictors of Cardiovascular Events after first generation DES
Implantation
Cox hazard model Hazard ratio 95.0% CI p value
Age 1.062 1.010-1.117 0.020
Duration after DES
implantation
1.03 1.003-1.057 0.026
ACh test positive unbalanced
data
Multinomial
logistic model Odds ratio 95.0% CI p value
Age 1.103 1.029–1.181 0.005
ACh test positive 12.671 1.544–104.001 0.018
Duration after DES
implantation
1.01 0.97–1.052 0.637
Conclusions: Coronary endothelial dysfunction evaluated by ACh provocation test at
stable stage is the strongest predictor of further prognosis in patients with first generation
DES.
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Background: Fractional flow reserve (FFR) is helpful to evaluate physiological severity
of coronary stenosis. Pharmacologic stimulus such as adenosine triphosphate (ATP) is
needed to obtain maximal hyperemia. Nicorandil, which is an ATP sensitive potassium
channel opener, recognized as vasodilator of epicardial and resistance vessels. However,
safety and feasibility of FFR with nicorandil has not been fully evaluated yet.
Methods: This study consisted of 32 patients with 39 de novo lesions which underwent
FFR measurements with both ATP and nicorandil stimulus. All patients first received
intravenous ATP infusion at a rate of 150 g/kg/min and measured FFR-ATP. After the
recovery to baseline was verified, patients received intracoronary nicorandil (1.5 mg to left
coronary artery or 1.0mg to right coronary artery) to obtain maximal hyperemia and
measured FFR-Nico.
Results: A total of 18 left anterior descending, 10 left circumflex, and 11 right coronary
arteries were evaluated. Mean diameter stenosis by QCA was 58.814.8%. A strong
correlation was observed between FFR-ATP and FFR-Nico (r0.960, p0.0001). The
agreement between the 2 sets of measurements was also high, with a mean difference of
0.0003 and 2SD of 0.0696. The mean aortic pressure drop during pharmacological
stimulus was significantly larger in ATP than in niocrandil (10.69.5 mmHg vs. 5.47.2
mmHg, p0.01).
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